Bruker (BRKR) Non-Current Debt (2010 - 2026)
Bruker's (BRKR) quarterly Non-Current Debt came in at $1.8 billion in Q2 2026, down 23.74% on a YoY basis from $2.4 billion in Q2 2025, and up 9.13% quarter-over-quarter from $1.7 billion in Q1 2026.
Analysis
Bruker (BRKR) Non-Current Debt (2010 - 2026) Analysis & Trends
Bruker (BRKR) has reported Non-Current Debt for 17 consecutive years, with $1.8 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Debt fell 23.74% year-over-year to $1.8 billion; the trailing twelve-month figure through Jun 2026 stood at $1.8 billion (down 23.74% YoY), and the FY2025 full-year result was $1.9 billion, down 10.15% from the prior year.
- Non-Current Debt advanced to $1.8 billion in Q2 2026 per BRKR's latest filing, from $1.7 billion in the prior quarter.
- Across five years, Non-Current Debt topped out at $2.4 billion in Q2 2025 and bottomed at $1.1 billion in Q3 2023.
- Historically, Non-Current Debt has averaged $1.6 billion across 5 years, with a median of $1.5 billion in 2024.
- The sharpest annual moves came in 2024 and 2026: Non-Current Debt soared 106.13% in 2024, then declined 23.74% in 2026.
- Over 5 years, Non-Current Debt stood at $1.2 billion in 2022, then decreased by 3.35% to $1.2 billion in 2023, then jumped by 77.7% to $2.1 billion in 2024, then retreated by 10.15% to $1.9 billion in 2025, then dropped by 2.04% to $1.8 billion in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $1.8 billion, $1.7 billion, and $1.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn | 42.28 Bn |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn | 26.56 Bn |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn | 3.65 Bn |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn | 1.49 Bn |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn | 2.63 Bn |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn | 200.00 Mn |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn | 1.20 Bn |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn | 551.05 Mn |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn | - |
| 10 | Bruker | 8.16 Bn | 7.94 Bn | 416.00 Mn | 1.81 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.81 Bn |
| Mar 31, 2026 | 1.66 Bn |
| Dec 31, 2025 | 1.85 Bn |
| Sep 30, 2025 | 1.98 Bn |
| Jun 30, 2025 | 2.38 Bn |
| Mar 31, 2025 | 2.08 Bn |
| Dec 31, 2024 | 2.06 Bn |
| Sep 30, 2024 | 2.26 Bn |
| Jun 30, 2024 | 2.13 Bn |
| Mar 31, 2024 | 1.36 Bn |
| Dec 31, 2023 | 1.16 Bn |
| Sep 30, 2023 | 1.10 Bn |
| Jun 30, 2023 | 1.12 Bn |
| Mar 31, 2023 | 1.11 Bn |
| Dec 31, 2022 | 1.20 Bn |
| Sep 30, 2022 | 1.14 Bn |
| Jun 30, 2022 | 1.17 Bn |
| Mar 31, 2022 | 1.21 Bn |
| Dec 31, 2021 | 1.22 Bn |
| Sep 30, 2021 | 827.00 Mn |